Voya Financial, Inc.·4

May 26, 4:55 PM ET

Leary Robert G 4

4 · Voya Financial, Inc. · Filed May 26, 2026

Research Summary

AI-generated summary of this filing

Updated

Voya (VOYA) Director Robert Leary Receives Award of 2,062 RSUs

What Happened
Robert G. Leary, a director of Voya Financial, received a grant of 2,062 restricted stock units (RSUs) on 2026-05-21. The grant is reported at an imputed price of $82.42 per share, for a total value of $169,950. This was an award/derivative grant (code A) — not an open‑market purchase or sale.

Key Details

  • Transaction date: 2026-05-21; reported on Form 4 filed 2026-05-26.
  • Grant details: 2,062 RSUs at $82.42 per share; total reported value $169,950.
  • Shares owned after transaction: not disclosed in the provided filing excerpt.
  • Footnotes: F1 — each stock unit represents a conditional right to receive one common share; F2 — 100% of the RSUs vest at 11:59 PM ET on the date of Voya’s 2027 Annual Meeting of Shareholders.
  • Timeliness: The Form 4 was filed five days after the transaction; Form 4s are generally due within two business days, so this appears to be a late filing.

Context
RSUs are a form of equity compensation that convert into actual shares (or their cash equivalent) only upon vesting. Because these units vest in full at the company’s 2027 annual meeting, they do not represent immediate stock ownership or an open‑market purchase. Grants to directors are typically part of routine compensation and should be interpreted as such; they do not by themselves indicate the director’s personal buying or selling sentiment.

Insider Transaction Report

Form 4
Period: 2026-05-21
Transactions
  • Award

    Restricted Stock Units

    [F1][F2]
    2026-05-21$82.42/sh+2,062$169,9506,664 total
    Common Stock (2,062 underlying)
Holdings
  • Common Stock

    868
Footnotes (2)
  • [F1]Each stock unit represents a conditional right to receive one share of the company's common stock.
  • [F2]100% of the restricted stock units will vest at 11:59pm Eastern Time on the date of the Company's 2027 Annual Meeting of Shareholders.
Signature
/s/ Julie Watson, Attorney-in-Fact|2026-05-26

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT